Thus, cytoskeletal elements, i.e., NF-L and others, might serve as biomarkers in neurological disorders, including stroke, to assess tissue damage and allow prognostication more precisely (Sharma et al., 2024). The gene discussed is NEFL; the disease is Stroke.